Filter posts

GAINing Ground in Antibiotics

With the rise of antibiotic resistant “superbugs” in recent years, everyone agrees there is an …

When Crop Vandalism Kills Children...

In the days following the senseless destruction of Golden Rice field trials in the Philippines …

Chinese In-Licensing Continues to Strengthen

Chinese companies are eager to collaborate with their ex-China counterparts, and in-licensing agreements are outpacing …

Fresenius v. Baxter: BIO files Amicus Brief in Federal Circuit

The Biotechnology Industry Organization filed an amicus brief at the Federal Circuit in the case …

BIO Investor Forum Company Snapshot: MAX BioPharma

Earlier this week, we featured a presenting company for our upcoming BIO Investor Forum event …

TTIP: Global Regulatory Cooperation and Convergence

The Transatlantic Trade and Investment Partnership (TTIP) initiative holds tremendous promise for the long-term competitiveness …

CSBI: New Study Outlines Potential Impact of Three Promising Tax Proposals

Ernst & Young recently released a study to determine the potential impact of three tax …

FDA Issues Final Guidance on Clinical Trial Oversight

The FDA released its final guidance governing clinical trial oversight and urges a risk-based approach …

BIO Investor Forum Company Snapshot: AM-Pharma

The BIO Investor Forum will be taking place this October in San Francisco for its …

Back to School: Time for Immunization Check-In

Preparing for school means gathering supplies and backpacks. It is also the perfect time to …